Nevertheless, other antibodies, particularly of the IgM type, could also be of interest in evaluating the treatment response of patients with early RA because their titres are elevated on antigen exposure before IgG antibody titres are elevated. This evidence concerns the gene CD40LG and rheumatoid arthritis.